PubMed:10029589
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-44 | DNA | denotes | Megakaryocyte/Platelet-specific enhancer |
| T2 | 52-77 | DNA | denotes | alpha2beta1 integrin gene |
| T3 | 90-99 | DNA | denotes | AP1 sites |
| T4 | 108-140 | protein | denotes | mitogen-activated protein kinase |
| T5 | 164-184 | protein | denotes | alpha2beta1 integrin |
| T6 | 209-218 | cell_type | denotes | platelets |
| T7 | 223-237 | cell_type | denotes | megakaryocytes |
| T8 | 315-335 | DNA | denotes | alpha2 integrin gene |
| T9 | 398-411 | DNA | denotes | core promoter |
| T10 | 438-446 | DNA | denotes | silencer |
| T11 | 476-500 | DNA | denotes | megakaryocytic enhancers |
| T12 | 508-523 | DNA | denotes | distal 5' flank |
| T13 | 550-563 | DNA | denotes | 229-bp region |
| T14 | 571-586 | DNA | denotes | distal 5' flank |
| T15 | 594-614 | DNA | denotes | alpha2 integrin gene |
| T16 | 628-665 | cell_type | denotes | high-level enhancer activity in cells |
| T17 | 707-724 | DNA | denotes | AP1 binding sites |
| T18 | 787-806 | protein | denotes | DNA-protein complex |
| T19 | 837-855 | protein | denotes | c-fos/c-jun family |
| T20 | 877-880 | protein | denotes | AP1 |
| T21 | 917-949 | protein | denotes | mitogen-activated protein kinase |
| T22 | 951-955 | protein | denotes | MAPK |
| T23 | 989-1009 | DNA | denotes | alpha2 integrin gene |
| T24 | 1040-1050 | protein | denotes | MAP kinase |
| T25 | 1097-1110 | protein | denotes | MAPK kinase 1 |
| T26 | 1144-1167 | protein | denotes | alpha2 integrin subunit |
| T27 | 1291-1311 | DNA | denotes | alpha2 integrin gene |
| T28 | 1339-1349 | protein | denotes | MAP kinase |
| T29 | 1381-1398 | DNA | denotes | AP1 binding sites |
| T30 | 1406-1430 | DNA | denotes | alpha2 integrin enhancer |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 48-77 | NP | denotes | the alpha2beta1 integrin gene |
| C2 | 160-184 | NP | denotes | The alpha2beta1 integrin |
| C3 | 186-237 | NP | denotes | a collagen receptor on platelets and megakaryocytes |
| C4 | 311-335 | NP | denotes | the alpha2 integrin gene |
| C5 | 356-386 | NP | denotes | megakaryocytic differentiation |
| C6 | 590-614 | NP | denotes | the alpha2 integrin gene |
| C7 | 989-1020 | NP | denotes | alpha2 integrin gene expression |
| C8 | 1064-1071 | NP | denotes | PD98059 |
| C9 | 1073-1110 | NP | denotes | a specific inhibitor of MAPK kinase 1 |
| C11 | 1233-1263 | NP | denotes | megakaryocytic differentiation |
| C10 | 1222-1263 | NP | denotes | a model of megakaryocytic differentiation |
| C12 | 1267-1272 | NP | denotes | which |
| C14 | 1287-1311 | NP | denotes | the alpha2 integrin gene |
| C13 | 1273-1311 | NP | denotes | expression of the alpha2 integrin gene |
| R1 | C3 | C2 | coref-appos | a collagen receptor on platelets and megakaryocytes,The alpha2beta1 integrin |
| R2 | C4 | C1 | coref-ident | the alpha2 integrin gene,the alpha2beta1 integrin gene |
| R3 | C6 | C4 | coref-ident | the alpha2 integrin gene,the alpha2 integrin gene |
| R4 | C9 | C8 | coref-appos | a specific inhibitor of MAPK kinase 1,PD98059 |
| R5 | C11 | C5 | coref-ident | megakaryocytic differentiation,megakaryocytic differentiation |
| R6 | C12 | C10 | coref-relat | which,a model of megakaryocytic differentiation |
| R7 | C14 | C6 | coref-ident | the alpha2 integrin gene,the alpha2 integrin gene |
| R8 | C13 | C7 | coref-ident | expression of the alpha2 integrin gene,alpha2 integrin gene expression |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-159 | Sentence | denotes | The Megakaryocyte/Platelet-specific enhancer of the alpha2beta1 integrin gene: two tandem AP1 sites and the mitogen-activated protein kinase signaling cascade. |
| S2 | 160-280 | Sentence | denotes | The alpha2beta1 integrin, a collagen receptor on platelets and megakaryocytes, is required for normal platelet function. |
| S3 | 281-524 | Sentence | denotes | Transcriptional regulation of the alpha2 integrin gene in cells undergoing megakaryocytic differentiation requires a core promoter between bp -30 and -92, a silencer between bp -92 and -351, and megakaryocytic enhancers in the distal 5' flank. |
| S4 | 525-695 | Sentence | denotes | We have now identified a 229-bp region of the distal 5' flank of the alpha2 integrin gene required for high-level enhancer activity in cells with megakaryocytic features. |
| S5 | 696-856 | Sentence | denotes | Two tandem AP1 binding sites with dyad symmetry are required for enhancer activity and for DNA-protein complex formation with members of the c-fos/c-jun family. |
| S6 | 857-1021 | Sentence | denotes | The requirement for AP1 activation suggested a role for the mitogen-activated protein kinase (MAPK) signaling pathway in regulating alpha2 integrin gene expression. |
| S7 | 1022-1210 | Sentence | denotes | Inhibition of the MAP kinase cascade with PD98059, a specific inhibitor of MAPK kinase 1, prevented the expression of the alpha2 integrin subunit in cells induced to become megakaryocytic. |
| S8 | 1211-1431 | Sentence | denotes | We provide a model of megakaryocytic differentiation in which expression of the alpha2 integrin gene requires signaling via the MAP kinase pathway to activate two tandem AP1 binding sites in the alpha2 integrin enhancer. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-44 | DNA_domain_or_region | denotes | Megakaryocyte/Platelet-specific enhancer |
| T2 | 52-77 | DNA_domain_or_region | denotes | alpha2beta1 integrin gene |
| T3 | 90-99 | DNA_domain_or_region | denotes | AP1 sites |
| T4 | 108-140 | protein_family_or_group | denotes | mitogen-activated protein kinase |
| T5 | 164-184 | protein_family_or_group | denotes | alpha2beta1 integrin |
| T6 | 209-218 | cell_type | denotes | platelets |
| T7 | 223-237 | cell_type | denotes | megakaryocytes |
| T8 | 255-279 | other_name | denotes | normal platelet function |
| T9 | 315-335 | DNA_domain_or_region | denotes | alpha2 integrin gene |
| T10 | 356-386 | other_name | denotes | megakaryocytic differentiation |
| T11 | 398-411 | DNA_domain_or_region | denotes | core promoter |
| T12 | 438-446 | DNA_family_or_group | denotes | silencer |
| T13 | 476-500 | DNA_domain_or_region | denotes | megakaryocytic enhancers |
| T14 | 508-523 | DNA_domain_or_region | denotes | distal 5' flank |
| T15 | 550-563 | DNA_domain_or_region | denotes | 229-bp region |
| T16 | 571-586 | DNA_domain_or_region | denotes | distal 5' flank |
| T17 | 594-614 | DNA_domain_or_region | denotes | alpha2 integrin gene |
| T18 | 628-665 | cell_type | denotes | high-level enhancer activity in cells |
| T19 | 671-694 | other_name | denotes | megakaryocytic features |
| T20 | 707-724 | DNA_domain_or_region | denotes | AP1 binding sites |
| T21 | 761-778 | other_name | denotes | enhancer activity |
| T22 | 787-806 | protein_complex | denotes | DNA-protein complex |
| T23 | 837-855 | protein_domain_or_region | denotes | c-fos/c-jun family |
| T24 | 877-880 | protein_molecule | denotes | AP1 |
| T25 | 917-949 | protein_family_or_group | denotes | mitogen-activated protein kinase |
| T26 | 951-955 | protein_family_or_group | denotes | MAPK |
| T27 | 989-1009 | DNA_domain_or_region | denotes | alpha2 integrin gene |
| T28 | 1040-1050 | protein_family_or_group | denotes | MAP kinase |
| T29 | 1064-1071 | other_organic_compound | denotes | PD98059 |
| T30 | 1097-1110 | protein_molecule | denotes | MAPK kinase 1 |
| T31 | 1144-1167 | protein_subunit | denotes | alpha2 integrin subunit |
| T32 | 1233-1263 | other_name | denotes | megakaryocytic differentiation |
| T33 | 1291-1311 | DNA_domain_or_region | denotes | alpha2 integrin gene |
| T34 | 1339-1349 | protein_family_or_group | denotes | MAP kinase |
| T35 | 1381-1398 | DNA_domain_or_region | denotes | AP1 binding sites |
| T36 | 1406-1430 | DNA_domain_or_region | denotes | alpha2 integrin enhancer |
2015-BEL-Sample-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| BEL:20043624 | 0-1020 | p(HGNC:JUN) increases r(HGNC:ITGA2) | denotes | The Megakaryocyte/Platelet-specific enhancer of the alpha2beta1 integrin gene: two tandem AP1 sites and the mitogen-activated protein kinase signaling cascade. The alpha2beta1 integrin, a collagen receptor on platelets and megakaryocytes, is required for normal platelet function. Transcriptional regulation of the alpha2 integrin gene in cells undergoing megakaryocytic differentiation requires a core promoter between bp -30 and -92, a silencer between bp -92 and -351, and megakaryocytic enhancers in the distal 5' flank. We have now identified a 229-bp region of the distal 5' flank of the alpha2 integrin gene required for high-level enhancer activity in cells with megakaryocytic features. Two tandem AP1 binding sites with dyad symmetry are required for enhancer activity and for DNA-protein complex formation with members of the c-fos/c-jun family. The requirement for AP1 activation suggested a role for the mitogen-activated protein kinase (MAPK) signaling pathway in regulating alpha2 integrin gene expression |
| BEL:20043794 | 0-1422 | p(HGNC:MAP2K1) increases r(HGNC:ITGA2B) | denotes | The Megakaryocyte/Platelet-specific enhancer of the alpha2beta1 integrin gene: two tandem AP1 sites and the mitogen-activated protein kinase signaling cascade. The alpha2beta1 integrin, a collagen receptor on platelets and megakaryocytes, is required for normal platelet function. Transcriptional regulation of the alpha2 integrin gene in cells undergoing megakaryocytic differentiation requires a core promoter between bp -30 and -92, a silencer between bp -92 and -351, and megakaryocytic enhancers in the distal 5' flank. We have now identified a 229-bp region of the distal 5' flank of the alpha2 integrin gene required for high-level enhancer activity in cells with megakaryocytic features. Two tandem AP1 binding sites with dyad symmetry are required for enhancer activity and for DNA-protein complex formation with members of the c-fos/c-jun family. The requirement for AP1 activation suggested a role for the mitogen-activated protein kinase (MAPK) signaling pathway in regulating alpha2 integrin gene expression. Inhibition of the MAP kinase cascade with PD98059, a specific inhibitor of MAPK kinase 1, prevented the expression of the alpha2 integrin subunit in cells induced to become megakaryocytic. We provide a model of megakaryocytic differentiation in which expression of the alpha2 integrin gene requires signaling via the MAP kinase pathway to activate two tandem AP1 binding sites in the alpha2 integrin |
| BEL:20043800 | 0-1422 | p(HGNC:MAP2K2) increases r(HGNC:ITGA2B) | denotes | The Megakaryocyte/Platelet-specific enhancer of the alpha2beta1 integrin gene: two tandem AP1 sites and the mitogen-activated protein kinase signaling cascade. The alpha2beta1 integrin, a collagen receptor on platelets and megakaryocytes, is required for normal platelet function. Transcriptional regulation of the alpha2 integrin gene in cells undergoing megakaryocytic differentiation requires a core promoter between bp -30 and -92, a silencer between bp -92 and -351, and megakaryocytic enhancers in the distal 5' flank. We have now identified a 229-bp region of the distal 5' flank of the alpha2 integrin gene required for high-level enhancer activity in cells with megakaryocytic features. Two tandem AP1 binding sites with dyad symmetry are required for enhancer activity and for DNA-protein complex formation with members of the c-fos/c-jun family. The requirement for AP1 activation suggested a role for the mitogen-activated protein kinase (MAPK) signaling pathway in regulating alpha2 integrin gene expression. Inhibition of the MAP kinase cascade with PD98059, a specific inhibitor of MAPK kinase 1, prevented the expression of the alpha2 integrin subunit in cells induced to become megakaryocytic. We provide a model of megakaryocytic differentiation in which expression of the alpha2 integrin gene requires signaling via the MAP kinase pathway to activate two tandem AP1 binding sites in the alpha2 integrin |